(Q39253157)

English

CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

0 references

author name string

T Nguyen-Hoai

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

O Hohn

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

M D Vu

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

G Baldenhofer

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

M S Sayed Ahmed

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

B Dörken

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

S Norley

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

M Lipp

8

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

A Pezzutto

9

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

J Westermann

10

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

26 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

880-887

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

DNA immunization targeting the skin: molecular control of adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

DNA vaccination against tumors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

DNA vaccines: precision tools for activating effective immunity against cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Induction of immune responses by DNA vaccines in large animals

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

TLR-based immune adjuvants.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Genetic adjuvants for DNA vaccines

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Chemical adjuvants for plasmid DNA vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Clinical utilization of chemokines to combat cancer: the double-edged sword

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Cancer immunotherapy with chemoattractant peptides.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Chemokine-chemokine receptors in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

T cells and their partners: The chemokine dating agency.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Orchestrating the orchestrators: chemokines in control of T cell traffic

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

CCR7 and its ligands: balancing immunity and tolerance

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

CCL19 (ELC) improves TH1-polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination model.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

The rationale for prophylactic cancer vaccines and need for a paradigm shift

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Quantitative measurement of anti-ErbB-2 antibody by flow cytometry and ELISA.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Cellular immunity to the Her-2/neu protooncogene

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Vaccination for treatment and prevention of cancer in animal models.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Langerhans cells - dendritic cells of the epidermis.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical disector method and the confocal laser scanning microscope.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

The gene gun: current applications in cutaneous gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Direct transfection and activation of human cutaneous dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

CCR7 is involved in the migration of neutrophils to lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Immunological monitoring of the tumor immunoenvironment for clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

B lymphocytes as antigen-presenting cell-based genetic vaccines

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

The role of B cells in regulating the magnitude of immune response.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

CpG-DNA aided cross-priming by cross-presenting B cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

B cells solicit their own help from T cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

B cells inhibit induction of T cell-dependent tumor immunity.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection against mammary tumor growth by vaccination with full-length, modified human ErbB-2 DNA.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with Her-2/neu DNA or protein subunits protects against growth of a Her-2/neu-expressing murine tumor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

7 January 2021

based on heuristic

inferred from DOI database lookup

B lymphocytes participate in cross-presentation of antigen following gene gun vaccination

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

7 January 2021

based on heuristic

inferred from DOI database lookup

Resting B cells suppress tumor immunity via an MHC class-II dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.78

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CGT.2012.78

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39253157&oldid=2202725336"